Exploratory study for prevention of nausea and vomiting switching from Granisetron + Dexamethasone (Day1-3) + Aprepitant (Day1-3) to Palonosetron + Dexamethasone (Day1) in patients given moderately emetogenic chemotherapy
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Interventions: GRA+DEX (Day1-3)+APR(Day1-3) PALO+DEX(Day1) Primary outcome(s): Nausea (Overall study period) Study Design: Single arm Non-randomized
创建时间：
2016-03-15
